Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation

被引:28
作者
Atsuta, Y
Suzuki, R
Yamamoto, K
Terakura, S
Iida, H
Kohno, A
Naoe, T
Yano, K
Wakita, A
Taji, H
Hamaguchi, M
Kodera, Y
Sao, H
Morishima, Y
Hamajima, N
Morishita, Y
机构
[1] Nagoya Univ, Grad Sch Med, Dept Prevent Med Biostat & Med Decis Making, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Aichi Canc Ctr, Div Mol Med, Nagoya, Aichi 464, Japan
[3] Japan Red Cross Nagoya First Hosp, Div Hematol, Nagoya, Aichi, Japan
[4] Meitetsu Hosp, Dept Hematol, Nagoya, Aichi, Japan
[5] JA Aichi Showa Hosp, Div Hematol & Oncol, Konan, Japan
[6] Nagoya Univ, Grad Sch Med, Dept Mol Med & Hematol, Nagoya, Aichi, Japan
[7] Hamamatsu Med Ctr, Div Infect Dis, Hamamatsu, Shizuoka, Japan
[8] Nagoya City Univ, Grad Sch Med Sci, Hamamatsu, Shizuoka, Japan
[9] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan
[10] Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan
关键词
chronic GVHD; Japanese; prognostic model; Karnofsky performance score; corticosteroids; infection;
D O I
10.1038/sj.bmt.1705247
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The incidence and prognostic factors for chronic graft-versus-host disease (cGVHD) were evaluated for 255 Japanese patients who survived more than 100 days after bone marrow transplantation, and of whom 119 (47%) developed cGVHD. Prior acute GVHD ( grade 2 - 4) and use of an unrelated donor were significantly associated with the onset of cGVHD. Presence of cGVHD did not have an impact on mortality ( hazard ratio (HR) 0.89; 95% confidence interval (CI), 0.59 - 1.3). Three factors at diagnosis were associated with cGVHD-specific survival: presence of infection ( HR 4.1; 95% CI, 1.6 - 10.3), continuing use of corticosteroids at the onset of cGVHD ( HR 3.9; 95% CI, 1.7 - 9.1), and a Karnofsky performance score <80 ( HR = 4.7; 95% CI, 2.0 - 11.3). The probability of cGVHD-specific survival at 4 years was 79% ( 95% CI, 70 - 86%). The severity and death rate of Japanese patients with cGVHD was lower than those for populations in Western countries, which might be the result of greater genetic homogeneity of Japanese ethnics. Our patients could not be accurately classified when the proposed prognostic models from Western countries were used, thus indicating the need for a different model to identify high-risk patients.
引用
收藏
页码:289 / 296
页数:8
相关论文
共 23 条
  • [1] Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study
    Akpek, G
    Lee, SJ
    Flowers, ME
    Pavletic, SZ
    Arora, M
    Lee, S
    Piantadosi, S
    Guthrie, KA
    Lynch, JC
    Takatu, A
    Horowitz, MM
    Antin, JH
    Weisdorf, DJ
    Martin, PJ
    Vogelsang, GB
    [J]. BLOOD, 2003, 102 (03) : 802 - 809
  • [2] Development of a prognostic model for grading chronic graft-versus-host disease
    Akpek, G
    Zahurak, ML
    Piantadosi, S
    Margolis, J
    Doherty, J
    Davidson, R
    Vogelsang, GB
    [J]. BLOOD, 2001, 97 (05) : 1219 - 1226
  • [3] ATKINSON K, 1990, BLOOD, V75, P2459
  • [4] Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis
    Carlens, S
    Ringdén, O
    Remberger, M
    Lönnqvist, B
    Hägglund, H
    Klaesson, S
    Mattsson, J
    Svahn, BM
    Winiarski, J
    Ljungman, P
    Aschan, J
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (08) : 755 - 761
  • [5] Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis
    Cutler, C
    Giri, S
    Jeyapalan, S
    Paniagua, D
    Viswanathan, A
    Antin, JH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3685 - 3691
  • [6] Farmer E R, 1986, Adv Dermatol, V1, P173
  • [7] Chronic graft versus host disease
    Higman, MA
    Vogelsang, GB
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (04) : 435 - 454
  • [8] Graft-versus-host disease (GVHD)-specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic haematopoietic cell transplantation
    Lee, JH
    Lee, JH
    Choi, SJ
    Kim, S
    Seol, M
    Lee, YS
    Lee, JS
    Kim, WK
    Lee, KH
    Kim, WK
    Lee, KH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (04) : 637 - 644
  • [9] Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
    Lee, SJ
    Klein, JP
    Barrett, AJ
    Ringden, O
    Antin, JH
    Cahn, JY
    Carabasi, MH
    Gale, RP
    Giralt, S
    Hale, GA
    Ilhan, O
    McCarthy, PL
    Socie, G
    Verdonck, LF
    Weisdorf, DJ
    Horowitz, MM
    [J]. BLOOD, 2002, 100 (02) : 406 - 414
  • [10] LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE BY THE ADMINISTRATION OF METHOTREXATE AND CYCLOSPORINE IN JAPANESE LEUKEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION FROM HUMAN-LEUKOCYTE ANTIGEN COMPATIBLE SIBLINGS - POSSIBLE ROLE OF GENETIC HOMOGENEITYT
    MORISHIMA, Y
    MORISHITA, Y
    TANIMOTO, M
    OHNO, R
    SAITO, H
    HORIBE, K
    HAMAJIMA, N
    NAITO, K
    YAMADA, K
    YOKOMAKU, S
    HIRABAYASHI, N
    YAMADA, H
    NAKAIDE, Y
    KOJIMA, S
    MINAMI, S
    MATSUYAMA, K
    KODERA, Y
    [J]. BLOOD, 1989, 74 (06) : 2252 - 2256